10.50 - 11.12
3.81 - 12.83
1.80M / 1.61M (Avg.)
158.14 | 0.07
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
31.84%
EBIT growth below 50% of IAUX's 100.00%. Michael Burry would suspect deeper competitive or cost structure issues.
31.84%
Positive operating income growth while IAUX is negative. John Neff might view this as a competitive edge in operations.
32.55%
Net income growth 1.25-1.5x IAUX's 26.67%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
32.46%
EPS growth at 50-75% of IAUX's 47.64%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
32.46%
Diluted EPS growth at 50-75% of IAUX's 47.64%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
71.10%
OCF growth at 50-75% of IAUX's 100.00%. Martin Whitman would question if the firm lags in monetizing sales effectively.
71.40%
FCF growth 50-75% of IAUX's 100.00%. Martin Whitman would see if structural disadvantages exist in generating free cash.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-81.60%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-81.60%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-81.60%
Negative 3Y OCF/share CAGR while IAUX stands at 100.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
75.43%
Positive 10Y CAGR while IAUX is negative. John Neff might see a substantial advantage in bottom-line trajectory.
75.43%
Positive 5Y CAGR while IAUX is negative. John Neff might view this as a strong mid-term relative advantage.
75.43%
Positive short-term CAGR while IAUX is negative. John Neff would see a clear advantage in near-term profit trajectory.
-78.19%
Negative equity/share CAGR over 10 years while IAUX stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-78.19%
Negative 5Y equity/share growth while IAUX is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-78.19%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-61.71%
Firm’s AR is declining while IAUX shows 100.09%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-100.00%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-3.10%
Negative asset growth while IAUX invests at 18.80%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-8.83%
We have a declining book value while IAUX shows 3.40%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-32.93%
We cut SG&A while IAUX invests at 47.05%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.